The
Gene Vector Laboratory is located in the Feigin Center of the Baylor-affiliated
Texas Children's Hospital, the largest pediatric hospital in the nation.
The laboratory occupies approximately 1,600 square feet on the 11th
floor, is fully self-contained, and has extensive dedicated equipment
required for large-scale vector production. The design follows the applicable
specifications of current Good Manufacturing Practices for Finished
Pharmaceuticals (CFR Title 21, Part 211, Sub-part C).
The laboratory is organized into six distinct areas: 1) a reception
area used for receipt of supplies and materials as well as an area for
storing the central supply of CO2 gas and LN2, freezer and storage units;
2) a quarantine tissue culture room; 3) a molecular laboratory for in-house
vector and procedure development; 4) a gowning and air-lock room that
separates the receiving, quarantine and molecular laboratory from the
production areas; 5) Suite A, the primary adenovirus production suite
which may also function as a retrovirus or ex-vivo transduction suite;
and 6) Suite B, composed of three independent suites. Suites B2 and
B3 are separated from Suite B1 by double weight glass doors and a positive
air pressure differential. Suite B1 functions as a clean area between
vector preparations in Suites B2 and B3.
Organizational structure is based on production teams, currently two
teams each composed of two technologists, under the direction of the
Laboratory Supervisor. The goal of the laboratory is to establish and
follow uncompromising, scientifically sound standard conditions for
production of gene therapy vectors used in Phase I/ II clinical trials.
This is a National Gene Vector Laboratory, and will make clinical grade adenoviral vectors without charge for investigators sponsored by the NGVL http://www.ngvl.org